SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

22 Apr 2024 07:00

RNS Number : 3269L
Cerillion PLC
22 April 2024
 

AIM: CER

 Cerillion plc

("Cerillion" or the "Company")

 

Half Year Trading Update

 

Record Six Months

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2024.

 

Results for the six-months ended 31 March 2024 are expected to set new highs for revenue and adjusted EBITDA. Revenue is expected to be approximately £22.5m (H1 2023: £20.5m) and adjusted EBITDA approximately £10.9m (H1 2023: £9.9m), both 10% higher year-on-year. Net cash at 31 March 2024 has increased to approximately £26.6m (31 March 2023: £23.6m), providing a very firm underpinning to the Company's strong balance sheet.  

 

The first half performance reflects ongoing strong demand from customers and the trading backdrop remains favourable. Telco digital transformation, the transition to Software-as-a-Service solutions and investment in enterprise software to achieve revenue and efficiency gains remain key features of the market, and consequently the Company's sales pipeline is strong. It includes a number of substantial potential new contracts, which are at various stages of the negotiation process. The Board believes that the Company remains well-placed to meet market expectations for the current financial year and beyond.

 

Notice of results

 

The Board expects to announce interim results on 13 May 2024, and will provide a further update on current trading at that time. 

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

 

 

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 80 customer installations across over 45 countries. Headquartered in London, Cerillion also has operations in India and Bulgaria.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMDRLMGDZG
Date   Source Headline
7th Feb 20209:57 amRNSResult of AGM
8th Jan 20208:58 amRNSHolding(s) in Company
8th Jan 20207:00 amRNSNotice of AGM
27th Nov 20192:52 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSTrading Update
14th Oct 20197:00 amRNSMajor Contract Win
26th Sep 20194:49 pmRNSHolding(s) in Company
9th Sep 20197:00 amRNSMajor New Contract Win
8th Aug 20194:14 pmRNSHolding(s) in Company
8th Aug 20194:13 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSMajor Contract Win
14th Jun 20197:00 amRNSMajor New Contract Win
20th May 20197:00 amRNSInterim Results
2nd May 20197:00 amRNSTrading Update and Notice of Results
21st Feb 20197:00 amRNSGartner Magic Quadrant Report
14th Feb 20194:01 pmRNSEmployee Share Option Scheme
13th Feb 20197:00 amRNSMajor New Contract Win
8th Feb 20193:16 pmRNSResult of AGM
25th Jan 20196:03 pmRNSNotice of AGM
26th Nov 20187:00 amRNSFinal Results
22nd Oct 20187:00 amRNSTrading Update
30th May 20187:00 amRNSTM Forum's 2018 Catalyst Awards
14th May 20187:00 amRNSInterim Results
16th Apr 20187:25 amRNSTrading Update & Notice of Results
5th Feb 201810:21 amRNSResult of AGM
17th Jan 20187:00 amRNSNotice of AGM and Posting of Annual Report
5th Dec 20177:00 amRNSMajor Contract Win
27th Nov 20177:00 amRNSFinal Results
17th Nov 20177:00 amRNSChange of Registered Office
30th Oct 20177:00 amRNSGartner Magic Quadrant Report
30th Oct 20177:00 amRNSTrading Update
20th Sep 20174:33 pmRNSHolding(s) in Company
19th Sep 20174:39 pmRNSImplementation of Long Term Incentive Plan
26th May 201710:13 amRNSCompletion of Director Placing
25th May 20175:00 pmRNSProposed Director Placing
22nd May 20177:00 amRNSInterim Results
9th May 20177:00 amRNSNotice of Results
10th Apr 20177:00 amRNSTrading Update
17th Mar 20177:00 amRNSMajor Contract Win
8th Feb 20174:11 pmRNSRe: New Employee Share Option Scheme
11th Jan 20175:47 pmRNSNotice of AGM and Posting of Annual Report
6th Jan 20177:00 amRNSNew Employee Share Option Scheme
21st Dec 20167:00 amRNSMajor Contract Win
1st Dec 20165:38 pmRNSRevised Dividend Timetable
28th Nov 20167:00 amRNSMajor Contract Win
28th Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSRe: Gartner's 2016 Magic Quadrant report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.